Precigen Inc

Financials

総資産 314.59 M359.86 M215.98 M151.04 M145.27 M155.5 M 負債合計 247.41 M252.51 M89.72 M32.55 M78.53 M134.59 M 純資産合計 67.17 M107.35 M126.26 M118.5 M38.51 M20.91 M 負債および純資産合計 314.59 M359.86 M215.98 M151.04 M145.27 M155.5 M 有利子負債合計 171.88 M183.15 M43.22 M——93.17 M 純負債 81.81 M78.64 M-47.75 M——-2.08 M

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

PGEN

Financials

Precigen Inc

ニュース

Inovio: "Hold" As Upcoming PDUFA For INO-3107 Is Major Inflection Point (NASDAQ:INO)

Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript

Precigen: The Best Potential Blockbuster You've Never Heard Of (Your ENT Has)

These Analysts Boost Their Forecasts On Precigen Following Q4 Results - Precigen (NASDAQ:PGEN)

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates

Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates

遺伝子治療の収益拡大に注目が集まるPrecigenの決算発表

Precigen earnings in focus as gene therapy revenue ramps up

CorMedix (CRMD) Lags Q4 Earnings Estimates

Precigen株が52週高値の5.23米ドルを記録

Precigen stock hits 52-week high at 5.23 USD